Oman: $150mln pharma factory opens in Salalah Free Zone

Salalah: The Philex Pharmaceuticals manufacturing factory in the Salalah Free Zone was opened on 25 January, 2023, under the patronage of Dr. Hilal Ali Al Sabti, Minister of Health. The manufacturer is an important contributor to securing the Omani markets with the pharmaceutical needs in the first place. It also seeks to export locally manufactured products to the GCC and Arab countries, as well as the African market shortly. The manufacturer, built according to international standard specifications, currently has local and global opportunities and operational plans. The drug products are marketed in Oman, Qatar, and other countries. The project included three stages of development; establishing an advanced pharmaceutical manufacturer and a development & research center. In the current stage, the manufacturer plans to produce more than 100 pharmaceuticals, including various types of medicines and vaccines in the next stages with a production capacity of one billion tablets and one billion capsules annually for the first stage. The manufacturer is the most recent project in the pharmaceutical field in the Sultanate of Oman, aiming to shift Salalah Free Zone to a regional center for pharmaceutical & biological industries with investments of about $150 million. With opening Philex factory, the total existing investments in pharmaceutical and medical factories reach nearly $200 million in Salalah Free Zone and Raysut Industrial Zone, with 7 factories. Dr. Ali Masoud Al Sunaidy, Chairman of the Public Authority for Special Economic Zones and Free Zones (OPAZ), said, “Opening this factory marks an added value to the pharmaceutical and medical industries in general in the Sultanate of Oman, and particularly in the free and industrial zones in Dhofar Governorate, which stands as an attractive investment environment for such industries.” He, further, added, “Today, we are observing the opening of the RO 23-million- value first phase of the factory, an equivalent of $60 million. The project’s production capacity is approximately one billion drug pills and one billion drug capsules for 50 medicinal items in this phase. Besides, it is expected that the factory will soon complete the project’s second and third phases, bringing the investment value to RO 58 million ($150 million)”. On the other hand, Al Sunaidy, pointed out, “Salalah Free Zone is currently a home for 2 more projects, with a value of RO 13,5 million ($35million) one for producing medical tools and another one under construction for producing medical supplies. In addition, there are 4 other factories in Raysut Industrial City producing injectable solutions, pharmaceuticals, medical gloves and masks, and other medical supplies, with investment value of RO 40 million ($104 million). Hence, the total investments in the pharmaceutical and medical industries in both zones reach over $200 million. This brings 3 factories for pharmaceuticals and 4 for medical supplies, one of which is on final stages. Overall, as the objective is to meet the local needs of medicine and medical supplies, a number of these factories are also exported to foreign markets. Moreover, lands have been allocated in Salalah Free Zone for the expansion of this factory, which we are celebrating today, and any pharmaceutical and medical factories that are expected to come in the future”. © Muscat Media Group Provided by SyndiGate Media Inc. (Syndigate.info).

Oman: $150mln pharma factory opens in Salalah Free Zone

DISCOVER MORE

Egypt’s Health Minister discuss bilateral cooperation with an Italian delegation

Saudi: Aldawaa Medical Services unveils 28% higher profits in 2022, dividends for H2-22

Saudi: SPIMACO shifts to over $45.6mln losses in 2022

UAE: Breakthrough by Emirati engineers could make prosthetic limbs cheaper, more easily available

DAHC, AXDEV Global, Pfizer Global Medical Grants partner for chronically ill patients' enhanced care

Moderna rebuked over plan to hike Covid vaccine to $130

Saudi: Mouwasat logs $159.73mln profits in 2022

Egypt seeks cooperation with Huawei Technologies to improve healthcare system

GCC central banks track US Fed move; hike key rates by 25bps

Dubai's Meraas to build new residential towers in Design District

VIDEO: LSE-listing will facilitate more funding opportunities for us, Dar Global CEO

Dubai’s Emirates to add value, support Air India – Tim Clark

Abu Dhabi's Mubadala, Ares set up $1bln JV to invest in credit secondaries

UAE: Acino announces integration of Pharmax Pharmaceuticals

Novo Nordisk plans to cut insulin prices in U.S. by up to 75%

Pfizer buys biotech firm Seagen for $43bln

U.S. FDA approves Acadia's genetic Rett syndrome drug

Indian court orders jail for two Maiden executives for shoddy drugs

LATEST VIDEO

VIDEO: LSE-listing will facilitate more funding opportunities for us, Dar Global CEO

ZAWYA COVERAGE

PODCAST: IFC is ready to back governments privatisation plans with capital

UAE's Presight AI to debut on Abu Dhabi Securities Exchange next week

Dubai's DEPA posts higher revenue for 2022 on post-COVID recovery

UAE exchange firm Al Ansari upsizes IPO on strong investor demand

Italy to cut rice output as drought looms for second year

Britain says it will update safeguards against financial market abuses

India cenbank has 'enough valid reasons' to pause rate hikes in April – ISEC PD

Russia's war on Ukraine latest: Kyiv prepares to launch counteroffensive

UK economy set to grow in Q1 and confidence is growing -flash PMI

THE BRI REPORT

China is reshaping the Belt and Road Initiative ahead of a post-pandemic era

DISCOVER MORE

LATEST VIDEO

ZAWYA NEWSLETTERS

ZAWYA COVERAGE